Fujifilm (OTCMKTS:FUJIY) Shares Gap Up - Here's Why

Key Points

• Fujifilm's shares surged before market opening on Friday, rising from a previous close of $11.99 to an opening price of $12.94, although they later traded at $12.41.
• The company reported earnings of $0.15 per share, meeting analysts' expectations, with a net margin of 7.93% and quarterly revenue of $5.08 billion.
• Fujifilm has a market capitalization of $30.79 billion and a price-to-earnings ratio of 11.15, indicating a strong market position and financial health.

Fujifilm Holdings Corp. (OTCMKTS:FUJIY - Get Free Report)'s share price gapped up before the market opened on Friday . The stock had previously closed at $11.99, but opened at $12.94. Fujifilm shares last traded at $12.41, with a volume of 10,122 shares traded.

Fujifilm Trading Up 3.2%

The stock has a market capitalization of $30.79 billion, a price-to-earnings ratio of 11.15, a PEG ratio of 2.33 and a beta of 0.67. The company's 50-day moving average is $11.64 and its 200-day moving average is $10.82. The company has a quick ratio of 0.92, a current ratio of 1.48 and a debt-to-equity ratio of 0.17.

Fujifilm (OTCMKTS:FUJIY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The technology company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. Fujifilm had a net margin of 7.93% and a return on equity of 7.60%. The firm had revenue of $5.08 billion during the quarter, compared to analysts' expectations of $760.41 billion. Research analysts anticipate that Fujifilm Holdings Corp. will post 0.66 earnings per share for the current fiscal year.

About Fujifilm

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.